TWI600904B - 皮膚應激蓄積度的評價方法 - Google Patents
皮膚應激蓄積度的評價方法 Download PDFInfo
- Publication number
- TWI600904B TWI600904B TW103104529A TW103104529A TWI600904B TW I600904 B TWI600904 B TW I600904B TW 103104529 A TW103104529 A TW 103104529A TW 103104529 A TW103104529 A TW 103104529A TW I600904 B TWI600904 B TW I600904B
- Authority
- TW
- Taiwan
- Prior art keywords
- skin
- amount
- stratum corneum
- protein
- stress
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 39
- 238000009825 accumulation Methods 0.000 title claims description 23
- 108010032428 Protein Deglycase DJ-1 Proteins 0.000 claims description 143
- 102000007659 Protein Deglycase DJ-1 Human genes 0.000 claims description 140
- 210000000434 stratum corneum Anatomy 0.000 claims description 76
- 210000003491 skin Anatomy 0.000 claims description 67
- 230000014509 gene expression Effects 0.000 claims description 46
- 238000011156 evaluation Methods 0.000 claims description 30
- 230000036074 healthy skin Effects 0.000 claims description 23
- 238000009826 distribution Methods 0.000 claims description 9
- 230000003647 oxidation Effects 0.000 claims description 6
- 238000007254 oxidation reaction Methods 0.000 claims description 6
- 230000006378 damage Effects 0.000 claims description 2
- 210000004027 cell Anatomy 0.000 description 50
- 108090000623 proteins and genes Proteins 0.000 description 50
- 102000004169 proteins and genes Human genes 0.000 description 49
- 230000035882 stress Effects 0.000 description 44
- 238000012360 testing method Methods 0.000 description 40
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 36
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 29
- 210000005175 epidermal keratinocyte Anatomy 0.000 description 19
- 230000037307 sensitive skin Effects 0.000 description 19
- 108010024636 Glutathione Proteins 0.000 description 18
- 229960003180 glutathione Drugs 0.000 description 18
- KJQFBVYMGADDTQ-CVSPRKDYSA-N L-buthionine-(S,R)-sulfoximine Chemical compound CCCCS(=N)(=O)CC[C@H](N)C(O)=O KJQFBVYMGADDTQ-CVSPRKDYSA-N 0.000 description 15
- 238000005259 measurement Methods 0.000 description 15
- 230000036542 oxidative stress Effects 0.000 description 14
- 239000002537 cosmetic Substances 0.000 description 11
- 239000012228 culture supernatant Substances 0.000 description 11
- 238000002835 absorbance Methods 0.000 description 9
- 239000003153 chemical reaction reagent Substances 0.000 description 9
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 8
- 102000003855 L-lactate dehydrogenase Human genes 0.000 description 8
- 108700023483 L-lactate dehydrogenases Proteins 0.000 description 8
- 108020004459 Small interfering RNA Proteins 0.000 description 8
- 229940098773 bovine serum albumin Drugs 0.000 description 8
- 239000013592 cell lysate Substances 0.000 description 8
- 230000003834 intracellular effect Effects 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- 239000002609 medium Substances 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 101150071263 PARK7 gene Proteins 0.000 description 6
- 239000012091 fetal bovine serum Substances 0.000 description 6
- 239000003112 inhibitor Substances 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 238000003556 assay Methods 0.000 description 5
- 238000012258 culturing Methods 0.000 description 5
- 239000013642 negative control Substances 0.000 description 5
- 238000010998 test method Methods 0.000 description 5
- 239000011324 bead Substances 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 210000002510 keratinocyte Anatomy 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- 230000005808 skin problem Effects 0.000 description 4
- 206010015150 Erythema Diseases 0.000 description 3
- 102000004142 Trypsin Human genes 0.000 description 3
- 108090000631 Trypsin Proteins 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000004113 cell culture Methods 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 231100000321 erythema Toxicity 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 230000007794 irritation Effects 0.000 description 3
- 239000010410 layer Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 239000012588 trypsin Substances 0.000 description 3
- 230000003313 weakening effect Effects 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- 238000008157 ELISA kit Methods 0.000 description 2
- 102000011782 Keratins Human genes 0.000 description 2
- 108010076876 Keratins Proteins 0.000 description 2
- 208000018737 Parkinson disease Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 239000012930 cell culture fluid Substances 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000001186 cumulative effect Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000002650 habitual effect Effects 0.000 description 2
- 230000001678 irradiating effect Effects 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000003716 rejuvenation Effects 0.000 description 2
- 230000003938 response to stress Effects 0.000 description 2
- 210000004927 skin cell Anatomy 0.000 description 2
- 206010040882 skin lesion Diseases 0.000 description 2
- 231100000444 skin lesion Toxicity 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 239000012096 transfection reagent Substances 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- 206010012689 Diabetic retinopathy Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 102000001109 Leukocyte L1 Antigen Complex Human genes 0.000 description 1
- 108010069316 Leukocyte L1 Antigen Complex Proteins 0.000 description 1
- 239000007987 MES buffer Substances 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 206010072170 Skin wound Diseases 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000002306 biochemical method Methods 0.000 description 1
- 238000010876 biochemical test Methods 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 208000029028 brain injury Diseases 0.000 description 1
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical class COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 230000006037 cell lysis Effects 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 230000002900 effect on cell Effects 0.000 description 1
- 230000001516 effect on protein Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000003127 radioimmunoassay Methods 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 238000002525 ultrasonication Methods 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013033567A JP5775540B2 (ja) | 2013-02-22 | 2013-02-22 | 皮膚の紫外線照射により負荷される紫外線ストレスの評価方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW201514494A TW201514494A (zh) | 2015-04-16 |
| TWI600904B true TWI600904B (zh) | 2017-10-01 |
Family
ID=51367814
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW103104529A TWI600904B (zh) | 2013-02-22 | 2014-02-12 | 皮膚應激蓄積度的評價方法 |
Country Status (4)
| Country | Link |
|---|---|
| JP (1) | JP5775540B2 (enExample) |
| CN (1) | CN104007057A (enExample) |
| HK (1) | HK1199098A1 (enExample) |
| TW (1) | TWI600904B (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6419654B2 (ja) * | 2015-06-22 | 2018-11-07 | 株式会社ファンケル | 発毛の状態及び頭皮の圧縮応力の評価方法 |
| JP7256069B2 (ja) * | 2019-05-10 | 2023-04-11 | 株式会社ファンケル | 生体の酸化ストレスの評価方法 |
| CN117990914A (zh) * | 2022-10-28 | 2024-05-07 | 生物岛实验室 | 肌少症的诊断标志物及其应用 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20120114628A1 (en) * | 2008-11-21 | 2012-05-10 | L'oreal | Cosmetic and therapeutic use of proteins of dj-1 type for treating skin dryness |
| TW201235662A (en) * | 2011-02-25 | 2012-09-01 | Fancl Corp | Method for evaluating stress accumulation degree of skin |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005075513A1 (ja) * | 2004-02-04 | 2005-08-18 | National Institute Of Advanced Industrial Science And Technology | システイン残基が酸化されたdj-1誘導体 |
| AU2006246957A1 (en) * | 2005-05-20 | 2006-11-23 | Premd, Inc. | Direct assay of skin protein in skin samples removed by tape stripping |
| CN103278641A (zh) * | 2005-10-21 | 2013-09-04 | 株式会社芳珂 | 特应性皮炎标记物及其利用技术 |
| US20090208985A1 (en) * | 2006-03-17 | 2009-08-20 | Chika Katagiri | Method Of Evaluating Degree Of Skin Sensitivity Using Squamous Cell Carcinoma Antigen As An Indicator Thereof |
| WO2009123373A1 (en) * | 2008-04-04 | 2009-10-08 | Goodgene Inc. | New skin sampling kit which stores nucleic acids in stable status, genetic test methods by using the kit and their practical application |
| JP5733839B2 (ja) * | 2010-03-26 | 2015-06-10 | 国立大学法人北海道大学 | 神経変性疾患治療薬 |
| CN101955908B (zh) * | 2010-07-22 | 2013-01-23 | 中国医学科学院皮肤病研究所 | 用于检测物质致敏性和药物筛选的人工表皮体外模型 |
| JP6419654B2 (ja) * | 2015-06-22 | 2018-11-07 | 株式会社ファンケル | 発毛の状態及び頭皮の圧縮応力の評価方法 |
-
2013
- 2013-02-22 JP JP2013033567A patent/JP5775540B2/ja active Active
-
2014
- 2014-02-12 TW TW103104529A patent/TWI600904B/zh not_active IP Right Cessation
- 2014-02-18 CN CN201410054223.6A patent/CN104007057A/zh active Pending
- 2014-12-15 HK HK14112554.7A patent/HK1199098A1/xx unknown
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20120114628A1 (en) * | 2008-11-21 | 2012-05-10 | L'oreal | Cosmetic and therapeutic use of proteins of dj-1 type for treating skin dryness |
| TW201235662A (en) * | 2011-02-25 | 2012-09-01 | Fancl Corp | Method for evaluating stress accumulation degree of skin |
Also Published As
| Publication number | Publication date |
|---|---|
| JP5775540B2 (ja) | 2015-09-09 |
| HK1199098A1 (en) | 2015-06-19 |
| TW201514494A (zh) | 2015-04-16 |
| JP2014163749A (ja) | 2014-09-08 |
| CN104007057A (zh) | 2014-08-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Farage | The prevalence of sensitive skin | |
| Guerra-Tapia et al. | Diagnosis and treatment of sensitive skin syndrome: an algorithm for clinical practice | |
| US11892447B2 (en) | Method for evaluating the effects of dehydration on children's skin | |
| TWI580964B (zh) | 皮膚的壓力蓄積度的評價方法 | |
| JP5653783B2 (ja) | 皮膚表皮内水分保持能評価法 | |
| TW201514494A (zh) | 皮膚應激蓄積度的評價方法 | |
| JP7820289B2 (ja) | 立毛筋細胞の賦活化による老化改善方法 | |
| US20150301064A1 (en) | Method of evaluating cellulite and method of evaluating cellulite-effective drug using fibulin-3 and/or sarcoglycan gamma as an indicator | |
| JP2014163715A (ja) | 紫外線傷害に対する抵抗性の評価方法 | |
| TW201430344A (zh) | 粗糙肌膚的評估方法 | |
| Lee et al. | Evaluation of the effects of a preparation containing asiaticoside on periocular wrinkles of human volunteers | |
| TWI541506B (zh) | 皮膚壓力蓄積的評價方法 | |
| JP2015024968A (ja) | 化粧料の選択方法 | |
| JP2016216436A (ja) | 皮膚粘弾性向上剤 | |
| Farage | Sensory, clinical, and physiological factors in sensitive skin | |
| Berna et al. | LB727 Using a machine learning approach to identify rare and low-frequency filaggrin variants associated with remission of Atopic Dermatitis | |
| Kalahasti et al. | LB726 The combination of 0.5% retinol with a naturally derived TRPV 1 antagonist and anti-inflammatory botanical extract helps mitigate retinoid-induced irritation | |
| Kim et al. | LB725 Skin barrier formation by epigenetic regulation of EGR3 | |
| Agarwal et al. | LB724 Human epidermal organoids: Establishing a reproducible stratified human epidermal organoid culture system | |
| KR101134088B1 (ko) | 피부자극 예측 평가방법 및 평가키트 | |
| HK1198451B (en) | Method for evaluating resistance to ultraviolet damage | |
| JP2012039970A (ja) | 皮膚損傷の程度を検査する方法 | |
| HK1187677A (en) | Method of evaluating degree of skin stress accumulation | |
| Robinson et al. | 34 Noninvasive Clinical Assessment | |
| Richters et al. | Conclusions and general discussion |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Annulment or lapse of patent due to non-payment of fees |